Olmesartan Medoxomil Tablets — Class III drug recall D-0392-2021
Terminated recall by Ascend Laboratories LLC, reported 2021-06-02, distributed nationwide. Presence of Foreign Tablet/Capsule
| Recall number | D-0392-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ascend Laboratories LLC, Parsippany, NJ, United States |
| Recall initiated | 2021-04-29 |
| Classified | 2021-05-24 |
| Reported by FDA | 2021-06-02 |
| Terminated | 2023-02-17 |
| Distributed | Nationwide (US) |
| Quantity | 34,296 bottles |
| NDC | 67877-0445, 67877-0445-05, 67877-0445-10, 67877-0445-30, 67877-0445-90, 67877-0446, 67877-0446-05, 67877-0446-10, 67877-0446-30, 67877-0446-33, 67877-0446-38, 67877-0446-74, 67877-0446-84, 67877-0446-90, 67877-0447, 67877-0447-05, 67877-0447-10, 67877-0447-30, 67877-0447-90 |
| Lot numbers | 20122548 |
| Expiration dates | 2022-08-20 |
Product
Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.
Reason for recall
Presence of Foreign Tablet/Capsule
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0392-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.